NNOX - Nano-X and Understanding the Risk/Reward Spectrum
In this episode of Industry Focus: Wildcard , we are bringing healthcare back into the spotlight, as the Nano-X .ARC (NASDAQ: NNOX) digital x-ray technology is getting 510(k) clearance from the Food and Drug Administration. Then, we use the company to explore the risk/reward spectrum and the trade-off of upside versus certainty with an investment.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . To get started investing, check out our quick-start guide to investing in stocks . A full transcript follows the video.
For further details see:
Nano-X and Understanding the Risk/Reward Spectrum